Pacific BioLabs

Executive Summary

Pacific BioLabs (PBL) is a well-established contract research organization (CRO) headquartered in San Carlos, California, with over 50 years of experience in preclinical and regulatory testing. Founded in 1972, the company provides a comprehensive suite of services including toxicology, pharmacology, biocompatibility, microbiology, sterility assurance, and analytical chemistry, all conducted under cGMP and GLP regulations. PBL serves a diverse client base ranging from small startups to large pharmaceutical and medical device companies, positioning itself as a trusted partner in drug and device development. The company’s longevity and regulatory expertise give it a competitive edge in the CRO market, though it remains privately held and relatively low-profile.

Upcoming Catalysts (preview)

• Q3 2026Expansion of GLP-compliant laboratory capacity70% success
• Q4 2026Strategic partnership with a gene therapy developer50% success
• Q2 2027Launch of advanced cell and gene therapy testing services60% success